triazoles has been researched along with Chagas Cardiomyopathy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Ferrão, PM; Garzoni, LR; Meuser-Batista, M; Moreira, OC; Nisimura, LM; Nogueira, ADR; Urbina, JA; Waghabi, MC | 1 |
Araújo-Jorge, TC; Calvet, CM; de Castro, SL; Molina, JT; Olivieri, BP; Pereira, MC; Urbina, JA | 1 |
Basombrío, MA; Cardozo, R; Corrales, M; Segura, MA; Urbina, JA | 1 |
Paugam, A | 1 |
1 review(s) available for triazoles and Chagas Cardiomyopathy
Article | Year |
---|---|
[The latest data on posaconazole].
Topics: Adult; Animals; Antifungal Agents; Central Nervous System Fungal Infections; Chagas Cardiomyopathy; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mice; Mycoses; Premedication; Triazoles; Trypanocidal Agents | 2007 |
3 other study(ies) available for triazoles and Chagas Cardiomyopathy
Article | Year |
---|---|
Effect of Posaconazole in an in vitro model of cardiac fibrosis induced by Trypanosoma cruzi.
Topics: Animals; Cell Culture Techniques; Chagas Cardiomyopathy; Endomyocardial Fibrosis; Extracellular Matrix Proteins; Fetus; Fibronectins; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Laminin; Mice; Models, Biological; Myocytes, Cardiac; Parasite Load; Primary Cell Culture; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease.
Topics: Animals; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Female; Heart; Humans; Mice; Myocardium; Nitroimidazoles; Survival Analysis; Triazoles; Trypanosoma cruzi | 2010 |
Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.
Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Ergosterol; Male; Mice; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2005 |